Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Knee Surgery, Sports Traumatology, Arthroscopy : Official Journal of the ESSKA|July 12, 2019
Redefining anterior ankle arthroscopic anatomy: medial and lateral ankle collateral ligaments are visible through dorsiflexion and non-distraction anterior ankle arthroscopyMiki Dalmau-Pastor, F Malagelada, G M Kerkhoffs, et al.
Knee Surgery, Sports Traumatology, Arthroscopy : Official Journal of the ESSKA|November 1, 2019
A step-by-step arthroscopic examination of the anterior ankle compartmentJ Vega, F Malagelada, J Karlsson, et al.
Journal of Cardiovascular Pharmacology|March 1, 1995
Pharmacology of LR-B/057, a novel orally active AT1 receptor antagonistA R Renzetti, P Cucchi, M Guelfi, et al.
European Review for Medical and Pharmacological Sciences|July 19, 2016
Amniotic fluid stem cells: an ideal resource for therapeutic application in bone tissue engineeringA Pantalone, I Antonucci, M Guelfi, et al.
Acta Geneticae Medicae Et Gemellologiae|January 1, 1996
Maternal uniparental disomy for chromosome 14D A Coviello, E Panucci, M M Mantero, et al.
European Journal of Pharmacology|March 14, 2001
Effect of a tachykinin NK(2) receptor antagonist, nepadutant, on cardiovascular and gastrointestinal function in rats and dogsS Giuliani, M Guelfi, M Toulouse, et al.
Biochemical and Biophysical Research Communications|July 24, 1998
Characterization of [3H]MEN 11420, a novel glycosylated peptide antagonist radioligand of the tachykinin NK2 receptorA R Renzetti, R M Catalioto, M Criscuoli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1996
Effect of adjuvant chemotherapy with or without anthracyclines on the activity and efficacy of first-line cyclophosphamide, epidoxorubicin, and fluorouracil in patients with metastatic breast cancerM Venturini, P Bruzzi, L Del Mastro, et al.
British Journal of Pharmacology|March 1, 1995
Pharmacology of LR-B/081, a new highly potent, selective and orally active, nonpeptide angiotensin II AT1 receptor antagonistR Cirillo, A R Renzetti, P Cucchi, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 20, 1999
Relevance of aromatic residues in transmembrane segments V to VII for binding of peptide and nonpeptide antagonists to the human tachykinin NK(2) receptorA R Renzetti, R M Catalioto, M Criscuoli, et al.
Pageof 3